Cargando…

Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans

BACKGROUND: Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease. The interleukin-6 (IL-6) receptor antagonist tocilizumab has been shown to lower serum Lp(a) concentrations. We investigated whether the IL-6 single nucleotide polymorphism −174G/C is associated with baselin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berthold, Heiner K., Laudes, Matthias, Krone, Wilhelm, Gouni-Berthold, Ioanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173458/ https://www.ncbi.nlm.nih.gov/pubmed/21935443 http://dx.doi.org/10.1371/journal.pone.0024719

Ejemplares similares

Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial
por: Berthold, Heiner K., et al.
Publicado: (2014)

Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2008)

Patterns and predictors of statin prescription in patients with type 2 diabetes
por: Berthold, Heiner K, et al.
Publicado: (2009)

Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2013)

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
por: Schultz, Olaf, et al.
Publicado: (2010)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Impact of Interleukin-6 –174 G>C Gene Promoter Polymorphism on Neuroblastoma
por: Totaro, Francesca, et al.
Publicado: (2013)

Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
por: Lorente, Leonardo, et al.
Publicado: (2016)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study
por: Sie, Mark PS, et al.
Publicado: (2008)

Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer
por: Zhai, Kan, et al.
Publicado: (2017)

Ethnic Variation in Interleukin-6 –174 (G/C) Polymorphism in the Malaysian Population
por: Gan, G-G, et al.
Publicado: (2013)

PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022)

Updates in Drug Treatment of Severe Hypertriglyceridemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2023)

Interleukin-6 c.-174G>C Polymorphism and Periodontitis in a Brazilian Population
por: Gabriela Teixeira, Fernanda, et al.
Publicado: (2014)

Influence of Interleukin-6 (174G/C) Gene Polymorphism on Obesity in Egyptian Children
por: Ibrahim, Ola M., et al.
Publicado: (2017)

Promoter Polymorphism (−174, G/C) of Interleukin-6 and Arterial Thromboembolic Events: A Meta-Analysis
por: Kim, Su Kang, et al.
Publicado: (2016)

Interleukin-6 -634 C/G and -174 G/C Polymorphisms in Korean Patients Undergoing Hemodialysis
por: Ryu, Jung-Hwa, et al.
Publicado: (2012)

Interleukin-6 and the IL-6 (–174) C/G polymorphism in breast pathologies and in HIV-infected patients
por: Jabłonowska, Elżbieta, et al.
Publicado: (2010)

Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance
por: Popko, K, et al.
Publicado: (2010)

The −174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype
por: Iacopetta, B, et al.
Publicado: (2004)

-174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease
por: Ghazouani, Lakhdar, et al.
Publicado: (2011)

Association of Interleukin-6–174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis
por: Chai, Jie, et al.
Publicado: (2022)

Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels
por: Berthold, Heiner K., et al.
Publicado: (2013)

Association between metabolic disturbances and G-174C polymorphism of interleukin-6 gene in obese children
por: Pyrzak, B, et al.
Publicado: (2009)

Evaluation the -174G>C Genetic Polymorphism of Interleukin-6 in Iranian Patients with Chronic Lymphocytic Leukemia
por: Rostamzadeh Khameneh, Zakieh, et al.
Publicado: (2023)

Meta‐analysis: Interleukin 6 gene ‐174G/C polymorphism associated with type 2 diabetes mellitus and interleukin 6 changes
por: Cheng, Hao, et al.
Publicado: (2021)

Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer
por: Wagh, Priyanka, et al.
Publicado: (2021)

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
por: Bamoulid, Jamal, et al.
Publicado: (2011)

Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides
por: Gouni-Berthold, Ioanna
Publicado: (2019)

INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN’S DISEASE AND ULCERATIVE COLITIS
por: Takač, Boris, et al.
Publicado: (2020)

The association between interleukin 6 −174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis
por: Fajar, Jonny K., et al.
Publicado: (2016)

Effect of interleukin 6 –174G>C gene polymorphism on opioid requirements after total hip replacement
por: Białecka, Monika, et al.
Publicado: (2016)

Gene Polymorphisms Increasing the Riskof Intracranial Aneurysms: Interleukin-6 -174G>C and -572G>C (Part II)
por: Giotta Lucifero, Alice, et al.
Publicado: (2021)

Effects of the IL6 −174G>C promoter polymorphism and IL-6 serum levels on the progression of cutaneous malignant melanoma
por: Vlaykova, Tatyana, et al.
Publicado: (2020)

A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease
por: Feng, Ye, et al.
Publicado: (2017)

Interleukin-6 -174 G/C polymorphism is associated with the risk of basal cell carcinoma in a Chinese Han population
por: Wang, Jing, et al.
Publicado: (2020)

Expression of suppressor of cytokine signaling 3 (SOCS3) and interleukin-6 (-174-G/C) polymorphism in atopic conditions
por: Jannat, Arooma, et al.
Publicado: (2019)

Correlation of interleukin-6-174 GC and interleukin-6-572 GC gene polymorphisms with periodontal disease in an Iranian population
por: Salman, Bahareh Nazemi, et al.
Publicado: (2016)

The −174G/C and −572G/C Interleukin 6 Promoter Gene Polymorphisms in Mexican Patients with Rheumatoid Arthritis: A Case-Control Study
por: Zavaleta-Muñiz, S. A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a8tkomirer37jhmofh4pi78der